Exodus Point Capital Management, LP Blueprint Medicines Corp Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 2,512 shares of BPMC stock, worth $232,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,512
Previous 3,383
25.75%
Holding current value
$232,309
Previous $313,000
30.03%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BPMC
# of Institutions
379Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$627 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$615 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$525 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$396 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$231 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.52B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...